For instance, a higher count of IFN-γ-producing cells than IL-17-producing cells in the muscles of patients with DM/PM has been reported, and the ratio of IFN-γ/IL-17-producing cells is connected to the therapeutic results of high-dose immunoglobulin. This evidence concerns the gene IFNG and dermatomyositis.